Trauma & major bleeding

Race and Ethnicity and Prehospital Use of Opioid or Ketamine Analgesia in Acute Traumatic Injury

JAMA Netw OpenPublished Retrospective cohort study

Authors' conclusion

In this nationwide study of patients treated by EMS for acute traumatic injuries, patients from racial or ethnic minority groups were less likely to have a pain score recorded, with Native American and Alaskan Natives the least likely to have a pain score recorded. Among patients with a high pain score, patients from racial and ethnic minority groups were also significantly less likely to receive opioid or ketamine analgesia treatment, with Black patients having the lowest adjusted odds of receiving these treatments.

Study context

Population
US patients aged 14 to 99 years with painful acute traumatic injuries (incl burns) treated and transported by an ALS unit after 911 EMS activation, 2019–2021
Participants
4,781,396 EMS activations
Exposure
Race and ethnicity categories vs White patients
  • Whiten = 2,764,499reference
  • American Indian or Alaskan Nativen = 31,266
  • Asiann = 59,713
  • Blackn = 742,931
  • Hispanic or Latinon = 411,934
  • Native Hawaiian or other Pacific Islandern = 10,747
  • Multiple racesn = 16,161
Outcome
Recording of a pain score; administration of a nonoral opioid or ketamine (when a high pain score is recorded)
Methodological detailsnationwide
  • Nationwide

Main finding

As reported in the abstract

Each group vs whiteAdjusted odds ratio (95% CI)
American Indian or Alaskan Nativepain score recorded; lowest aOR
0.74(0.71–0.76)
Blackopioid or ketamine analgesia among patients with high pain score (7–10 of 10)
0.53(0.52–0.54)

Observational data: associations, not effects.

Original publication

Race and Ethnicity and Prehospital Use of Opioid or Ketamine Analgesia in Acute Traumatic Injury. JAMA Netw Open. Published 2 October 2023. doi:10.1001/jamanetworkopen.2023.38070

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.